Target intelligence / Profile preview

Reactive oxygen species (ROS) and lipid-derived free radicals (LFRs) (ROS/LFRs)

Target
ROS/LFRs
Molecular classification
Reactive species, Free radicals, Non-proteinaceous molecules
01

Overview

Reactive oxygen species (ROS) and lipid-derived free radicals (LFRs) are highly reactive chemical species generated as byproducts of aerobic metabolism or in response to exogenous stressors like radiation and toxins (NIH, 2023). In the lipid-rich environment of cellular membranes, these radicals—specifically lipid peroxyl (LOO•) and alkoxyl (LO•) radicals—drive the process of lipid peroxidation, which involves the oxidative degradation of polyunsaturated fatty acids (PubMed, PMID: 24903357). This process disrupts membrane fluidity, permeability, and the function of membrane-bound proteins, ultimately leading to cell death via pathways like ferroptosis (Nature, 2017). While ROS serve as critical secondary messengers in physiological signaling at low concentrations, their chronic elevation is implicated in the progression of neurodegenerative diseases, cardiovascular disorders, and chronic inflammation (StatPearls, 2023). Therapeutic targeting of these species involves the administration of lipophilic antioxidants and radical scavengers, such as Edaravone or Vitamin E, which localize to the membrane to neutralize radicals and terminate the self-propagating chain reaction (PubChem).

Other names
Oxidative stress mediatorsLipid peroxyl radicalsLipid hydroperoxidesOxygen radicalsMembrane-associated free radicalsLipid-derived radicals
02

Mechanism of action

Neutralization of reactive species through radical scavenging and termination of lipid peroxidation chain reactions.

03

Biological functions

Cell signalingOxidative stressLipid peroxidationMembrane damageFerroptosisSignal transduction
04

Disease associations

Amyotrophic lateral sclerosisAlzheimer's diseaseCardiovascular diseaseIschemia-reperfusion injuryInflammationCancer
05

Safety considerations

Interference with physiological redox signalingPotential pro-oxidant activityChallenges in membrane-specific deliveryOff-target effects on essential metabolic ROS
06

Interacting drugs

Edaravone

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)8-IsoprostaneProtein carbonyls

Beyond the preview

Go deeper on Reactive oxygen species (ROS) and lipid-derived free radicals (LFRs) (ROS/LFRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species (ROS) and lipid-derived free radicals (LFRs) (ROS/LFRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call